Symptom-Based Screening Tool Successfully Identifies Young Children with High Asthma Risk
November 10th 2022The tool successfully identified children with high asthma risk as young as 3 years of age. The screening tool was found to be more accurate at predicting asthma, persistent wheezing, and related emergency room visits and hospitalizations than standard screening and diagnostic tools.
Read More
Mindfulness-Based Stress Reduction Improves Asthma Control and Reduces Airway Inflammation
November 9th 2022University of Wisconsin researchers find that people with asthma benefit from intervention that includes meditation and yoga and sustained focus on the breathing, thoughts, feelings, and bodily sensations.
Read More
Gene Therapies for Hemophilia. Possibly Curative, Likely Ultraexpensive
September 8th 2022Three gene therapies in late-stage development are designed to supply working copies of genes that people with hemophilia are missing. They may be one-time, curative treatments, but the seven-figure price tags will be an issue.
Read More
Cost Effectiveness Analysis of Biomarkers for Guiding Asthma Treatment in Children
August 2nd 2022Using biomarkers for tailoring asthma treatment can reduce the frequency of asthma exacerbations. Some recent results suggest that eosinophil-guided asthma management is associated with lower annual costs than FeNO-guided management.
Read More
American Academy of Family Physicians Awarded $31 Million for Comparative Asthma Treatment Study
August 1st 2022The Patient-Centered Outcomes Research Institute (PCORI) has approved an award for the American Academy of Family Physicians (AAFP) of $31 million to fund a large comparative study of asthma treatments.
Read More
Dupixent Combined with House Dust Mite SLIT May Help Improve Control in Allergic Asthma
July 15th 2022House dust mites after a common trigger for allergic asthma. Guidelines recommend house dust mite sublingual immunotherapy as add-on therapy for patients with house dust mite-related allergic asthma.
Read More
IL-13 in People with Allergic Asthma May Offer Some Protection Against Severe COVID
June 14th 2022University of North Carolina researchers report that interleukin-13, responsible for inflammation and severe asthma symptoms, may have properties that fend off the SARS-CoV-2 virus that causes COVID-19.
Read More